Navigation Links
Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
Date:8/30/2007

1b trial evaluating the safety and tolerability of MT201 in combination with docetaxel is currently ongoing in patients with metastatic breast cancer. Our third clinical stage product candidate is D93, also known as TRC093, a first-in- class humanized monoclonal antibody that inhibits angiogenesis and tumor cell growth by binding cleaved collagen. This product candidate is in phase 1 clinical trials and is being developed by TRACON Pharmaceuticals for the treatment of patients with cancer and age-related macular degeneration pursuant to license agreement under which Micromet has granted TRACON the worldwide rights to develop and commercialize D93/TRC093. In addition, Micromet has established a collaboration with Nycomed for the development and commercialization of MT203, Micromet's human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of inflammatory diseases, such as rheumatoid arthritis, as well as autoimmune diseases.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... International, Inc. (NASDAQ: YONG ) ("Yongye" or ... crop nutrient products in the People,s Republic ... 16, 2013, the special committee (the "Special Committee") of ... provided a letter (the "Letter") issued by Abax Global ... to Full Alliance International Limited ("Full Alliance"). The Letter, ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ ... help predict the adverse and therapeutic effects of a ... Computational Biology at the Genomics Laboratory, Covance, will discuss ... genomics when used as part of the QC process. ... sets to identify key clinical targets even in complex ...
(Date:5/17/2013)... Tooth decay is an epidemic in American children with ... The World Health Organization says that worldwide, 60–90% ... What are the long-term effects of this transmissible infection? ... the oral bacterial imbalance and serious systemic issues like heart ... is also 100% preventable? Answer: there has been no way ...
(Date:5/16/2013)... May 16, 2013 In late 2012, Dr. ... speak to doctors in China about Appearance Medicine . ... this was her first trip to lecture in China, and ... Guangzhou and Fuzhou, home to 12 and 7 million people ... very high at this point in time. As Dr. Hart ...
Breaking Biology Technology:Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3
... Northwestern University have developed a model that will allow them ... around them. The model enables further research that may provide ... of papers are published each year that use the rat ... neural processing. Rats move their whiskers rhythmically against objects to ...
... April 7, 2011 Sangamo BioSciences, Inc. (Nasdaq: ... 6,700,000 shares of its common stock pursuant to an effective ... Inc. is the sole book-running manager in this offering and ... to purchase up to 1,005,000 additional shares. ...
... WORCESTER, Mass. and TORONTO, April 7, 2011  Generex ... that this week there will be presentations of ... the Company,s proprietary buccal insulin spray product, at ... The presentations, entitled "Use of Buccal ...
Cached Biology Technology:New model of whiskers provides insight into sense of touch 2New model of whiskers provides insight into sense of touch 3Sangamo Announces Public Offering of Common Stock 2Sangamo Announces Public Offering of Common Stock 3Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia 2Generex Oral-lyn™ Data to be Presented at Two International Scientific Symposia 3
(Date:5/17/2013)... University of New Jersey, and City University of New ... TM that effectively clears organisms to be viewed ... chloral hydrate, which is one of the few high-quality ... by the Drug Enforcement Administration (DEA) due to its ... agents, are vital for viewing organisms under a microscope. ...
(Date:5/17/2013)... in Efficient and Sustainable Global Logistics Operations) is aiming ... the efficiency of intermodal loading systems and the boosting ... 29 European organisations with experience in the logistics sector ... totalling 17,000,000 and a duration of three and a ... develop the semantic components and ontologies shared by the ...
(Date:5/16/2013)... MD (May 17, 2013) Illustrating a commitment ... American Gastroenterological Association (AGA) Research Foundation has ... Student Research Fellowship Award recipients. Supported by the ... Diseases (NIDDK), this new award helps underrepresented minority ... disease and nutrition research. , "By establishing this ...
Breaking Biology News(10 mins):New formula invented for microscope viewing, substitutes for federally controlled drug 2New formula invented for microscope viewing, substitutes for federally controlled drug 3New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2
... our brain to learn and remember better, says a new ... at The University of Texas at Austin. The common ... wrong, says neurobiologist Hitoshi Morikawa, but it highlights only one ... "Usually, when we talk about learning and memory, we,re talking ...
... in a helicopter netting operation on February 28, fitted with ... off" of the animals at a future date through an ... with tracking data collected during the migration of the animals ... Mountains, Pahsimeroi Valley, Lemhi Valley of Idaho, Horse Prairie and ...
... to cause physical and behavioral changes in marine life, especially ... activities. However, low frequency sound produced by large scale, offshore ... harm to other marine life as well. Giant squid, for ... 2001 and 2003 following the use of airguns by offshore ...
Cached Biology News:Alcohol helps the brain remember, says new study 2Wildlife Conservation Society and Idaho Fish and Game track pronghorn by satellite 2Cephalopods experience massive acoustic trauma from noise pollution in the oceans 2
... reagent is formulated specifically for Alkaline Phosphatase ... levels of activity for both the enzyme ... final dilution. This product has been ... the customer a longer shelf life, resistance ...
... a valuable tool for removing SDS detergent ... SDS in biological samples imparts a negative ... inhibits enzymatic activity during digestion, and suppresses ... in mass spectrometry analyses. We recommend ...
Cells are grown in triple flasks, roller bottles, or NUNC Factory. Viability and growth curves are generated from a parallel representative culture....
... cost effective cell culture services for the ... Quality at a reasonable price is our ... or commercial product, we strive toward customer ... roller bottles, hollow fiber, and bioreactor technologies, ...
Biology Products: